Round Rock Advisors, LLC Xeris Biopharma Holdings, Inc. Transaction History
Round Rock Advisors, LLC
- $627 Million
- Q4 2025
A detailed history of Round Rock Advisors, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Round Rock Advisors, LLC holds 96,816 shares of XERS stock, worth $701,916. This represents 0.11% of its overall portfolio holdings.
Number of Shares
96,816
Previous 63,772
51.82%
Holding current value
$701,916
Previous $516,000
35.85%
% of portfolio
0.11%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
237Shares Held
94.4MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...